ACS Pharmacology & Translational Science

ACS Pharmacology & Translational Science is a peer-reviewed journal from the American Chemical Society and ACS Publications. Its editorial team is preparing to publish a special issue on psychedelics for treating mental illness in early 2021 under the supervision of guest editor, Assistant Professor David Olson of the University of California, Davis, Department of Chemistry and Department of Biochemistry & Molecular Medicine.

ACS Pharmacology & Translational Science publishes high-quality, innovative research across the broad spectrum of biological sciences—from basic and molecular sciences to translational preclinical studies. Its editors also consider clinical studies that address novel mechanisms of action and methodological papers that provide innovation and advance translation.

ACS Pharmacology & Translational Science has no charges or fees to submit a manuscript or to publish an article under the traditional subscription model (non-open-access). That means no author charges, page charges, processing charges, or color charges. It is a hybrid journal that allows authors to choose to publish their article open access. There is an article publication charge (APC) to publish an article open access.

View in the Microdose DirectoryVisit Website